_version_ 1784685572785176576
author Chavarot, Nathalie
Melenotte, Clea
Amrouche, Lucile
Rouzaud, Claire
Sberro-Soussan, Rebecca
Pavie, Juliette
Martinez, Frank
Pouvaret, Anne
Leruez-Ville, Marianne
Cantin, Delphine
Fourgeaud, Jacques
Delage, Claire
Vimpere, Damien
Peraldi, Marie Noëlle
Legendre, Christophe
Lanternier, Fanny
Zuber, Julien
Scemla, Anne
Anglicheau, Dany
author_facet Chavarot, Nathalie
Melenotte, Clea
Amrouche, Lucile
Rouzaud, Claire
Sberro-Soussan, Rebecca
Pavie, Juliette
Martinez, Frank
Pouvaret, Anne
Leruez-Ville, Marianne
Cantin, Delphine
Fourgeaud, Jacques
Delage, Claire
Vimpere, Damien
Peraldi, Marie Noëlle
Legendre, Christophe
Lanternier, Fanny
Zuber, Julien
Scemla, Anne
Anglicheau, Dany
author_sort Chavarot, Nathalie
collection PubMed
description
format Online
Article
Text
id pubmed-9001009
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Society of Nephrology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-90010092022-04-12 Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection Chavarot, Nathalie Melenotte, Clea Amrouche, Lucile Rouzaud, Claire Sberro-Soussan, Rebecca Pavie, Juliette Martinez, Frank Pouvaret, Anne Leruez-Ville, Marianne Cantin, Delphine Fourgeaud, Jacques Delage, Claire Vimpere, Damien Peraldi, Marie Noëlle Legendre, Christophe Lanternier, Fanny Zuber, Julien Scemla, Anne Anglicheau, Dany Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2022-06 2022-04-12 /pmc/articles/PMC9001009/ /pubmed/35421508 http://dx.doi.org/10.1016/j.kint.2022.04.003 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Chavarot, Nathalie
Melenotte, Clea
Amrouche, Lucile
Rouzaud, Claire
Sberro-Soussan, Rebecca
Pavie, Juliette
Martinez, Frank
Pouvaret, Anne
Leruez-Ville, Marianne
Cantin, Delphine
Fourgeaud, Jacques
Delage, Claire
Vimpere, Damien
Peraldi, Marie Noëlle
Legendre, Christophe
Lanternier, Fanny
Zuber, Julien
Scemla, Anne
Anglicheau, Dany
Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
title Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
title_full Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
title_fullStr Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
title_full_unstemmed Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
title_short Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
title_sort early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with omicron infection
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001009/
https://www.ncbi.nlm.nih.gov/pubmed/35421508
http://dx.doi.org/10.1016/j.kint.2022.04.003
work_keys_str_mv AT chavarotnathalie earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT melenotteclea earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT amrouchelucile earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT rouzaudclaire earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT sberrosoussanrebecca earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT paviejuliette earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT martinezfrank earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT pouvaretanne earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT leruezvillemarianne earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT cantindelphine earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT fourgeaudjacques earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT delageclaire earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT vimperedamien earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT peraldimarienoelle earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT legendrechristophe earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT lanternierfanny earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT zuberjulien earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT scemlaanne earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection
AT anglicheaudany earlytreatmentwithsotrovimabmonoclonalantibodyinkidneytransplantrecipientswithomicroninfection